Northern Trust’s Traws Pharma TRAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.6K | Buy |
+37,454
| New | +$51.6K | ﹤0.01% | 4324 |
|
|
2024
Q3 | – | Sell |
-1,226
| Closed | -$13.7K | – | 4458 |
|
|
2024
Q2 | $13.7K | Sell |
1,226
-5
| -0.4% | -$81 | ﹤0.01% | 4358 |
|
|
2024
Q1 | $31.1K | Hold |
1,231
| – | – | ﹤0.01% | 4291 |
|
|
2023
Q4 | $23K | Hold |
1,231
| – | – | ﹤0.01% | 4350 |
|
|
2023
Q3 | $21.9K | Hold |
1,231
| – | – | ﹤0.01% | 4321 |
|
|
2023
Q2 | $36.3K | Hold |
1,231
| – | – | ﹤0.01% | 4291 |
|
|
2023
Q1 | $22.5K | Hold |
1,231
| – | – | ﹤0.01% | 4428 |
|
|
2022
Q4 | $19.9K | Hold |
1,231
| – | – | ﹤0.01% | 4490 |
|
|
2022
Q3 | $27K | Hold |
1,231
| – | – | ﹤0.01% | 4490 |
|
|
2022
Q2 | $41K | Hold |
1,231
| – | – | ﹤0.01% | 4464 |
|
|
2022
Q1 | $57K | Hold |
1,231
| – | – | ﹤0.01% | 4505 |
|
|
2021
Q4 | $78K | Hold |
1,231
| – | – | ﹤0.01% | 4493 |
|
|
2021
Q3 | $118K | Sell |
1,231
-61
| -5% | -$7.86K | ﹤0.01% | 4362 |
|
|
2021
Q2 | $224K | Buy |
1,292
+187
| +17% | +$42.3K | ﹤0.01% | 4108 |
|
|
2021
Q1 | $414K | Buy |
1,105
+378
| +52% | +$143K | ﹤0.01% | 3876 |
|
|
2020
Q4 | $127K | Sell |
727
-20
| -3% | -$2.32K | ﹤0.01% | 4070 |
|
|
2020
Q3 | $78K | Buy |
747
+230
| +44% | +$56.9K | ﹤0.01% | 4019 |
|
|
2020
Q2 | $110K | Buy |
517
+342
| +195% | +$52.3K | ﹤0.01% | 3895 |
|
|
2020
Q1 | $20K | Buy |
+175
| New | +$27.5K | ﹤0.01% | 4090 |
|
|
2018
Q3 | – | Sell |
-3
| Closed | -$8K | – | 4339 |
|
|
2018
Q2 | $8K | Hold |
3
| – | – | ﹤0.01% | 4263 |
|
|
2018
Q1 | $16K | Buy |
+3
| New | +$21.4K | ﹤0.01% | 4183 |
|
|
2016
Q2 | – | Hold |
0
| – | -$11K | – | 4279 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4171 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4182 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4165 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 4121 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 4198 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 4115 |
|
|
2014
Q3 | – | Sell |
-1
| Closed | -$285K | – | 4129 |
|
|
2014
Q2 | $329K | Hold |
1
| – | – | ﹤0.01% | 3717 |
|
|
2014
Q1 | $479K | Hold |
1
| – | – | ﹤0.01% | 3551 |
|
|
2013
Q4 | $937K | Hold |
1
| – | – | ﹤0.01% | 3398 |
|
|
2013
Q3 | $824K | Buy |
+1
| New | +$1.43M | ﹤0.01% | 3373 |
|
Other funds holding TRAW
O
ABG
ACM
LCM
IC
SFM
Northern Trust's TRAW Position: Q2 2026 in Review
Northern Trust opened a new position in Traws Pharma (TRAW) in Q2 2026: 37,454 shares worth $31.6K. The stake represents ﹤0.01% of the portfolio and ranks #4324 among its holdings. This is a return to the name: Northern Trust previously reported a position in TRAW as recently as Q2 2024.
Northern Trust first reported a position in TRAW in Q3 2013 and has held it in 25 quarters since. The position peaked at $937K in Q4 2013. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.
- Northern Trust held 37,454 shares of Traws Pharma worth $31.6K as of Q2 2026.
- Traws Pharma was a new Northern Trust position in Q2 2026.
- Traws Pharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4324 holding.
- Northern Trust first reported a position in Traws Pharma in Q3 2013 and has held it in 25 quarters since.
- Northern Trust's Traws Pharma position peaked at $937K in Q4 2013.
- 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.